Redsense Medical attending US dialysis conferences this spring
Redsense Medical will be exhibiting at several US dialysis conferences this March and April. These events are effective ways for Redsense to engage with all the important dialysis care givers, from dialysis providers, physicians, nurses, technicians, manufacturers and distributors. Redsense will exhibit at the following events:
- Annual Dialysis Conference, March 8-10, 2024, San Diego, CA
- NANT-DialysisTechConneXion 41, March 25-27, 2024, Las Vegas, NV
- RPA 2024 Annual Meeting, April 11-14, 2024, Baltimore, MD
- ANNA National Symposium, April 14-17, 2024, Orlando, FL
“We look forward to exhibiting and showcasing Redsense products at these upcoming conferences in the months ahead. These conferences provide excellent opportunities for Redsense to engage with patient care professionals in the dialysis community and to promote patient safety with the Redsense Alarm system.”, says Brendan Kane, Redsense U.S. Director of Sales.
Contact information
For more information, please contact:
Pontus Nobréus, CEO
Telephone: +46 72-171 1264
E-mail: pontus.nobreus (at) redsensemedical.com
Redsense Medical AB (publ), 556646-4862
ABOUT REDSENSE MEDICAL
Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovation used for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector. The Redsense Medical share is listed on Spotlight Stock Market (REDS) and traded on OTCQX (RDSNF) in the US.